omega-n-methylarginine has been researched along with Coronary Disease in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (46.43) | 18.2507 |
2000's | 15 (53.57) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hironaga, K; Hirooka, Y; Oyama, J; Sakai, K; Shimokawa, H; Tagawa, T; Takeshita, A | 1 |
Boger, RH; Flyvbjerg, A; Frystyk, J; Ledet, T; Moller, N; Orskov, H | 1 |
Delp, MD; Fogarty, JA; Laughlin, MH; Mattox, ML; Muller-Delp, JM; Parker, JL | 1 |
Hayashida, Y; Morishita, T; Nakashima, Y; Nakata, S; Sasaguri, Y; Suda, O; Tasaki, H; Toyohira, Y; Tsujimoto, T; Tsutsui, M; Ueno, S; Ueta, Y; Yanagihara, N | 1 |
Bi, X; Chang, Q; Deng, Y; Li, C; Li, T; Liu, J; Wang, L; Yang, H; Zhang, Q | 1 |
Ferguson, JJ; Igo, SR; Macris, MP; Ober, JC; Willerson, JT; Yao, SK | 1 |
Egashira, K; Hirakawa, Y; Katsuda, Y; Kubota, T; Kuga, T; Mohri, M; Tagawa, T; Takeshita, A | 1 |
Creager, MA; Ganz, P; Gerhard, MD; Lieberman, EH; Selwyn, AP; Uehata, A; Yeung, AC | 1 |
Crake, T; Davies, G; Tentolouris, C; Tousoulis, D; Toutouzas, P | 2 |
Egashira, K; Hirakawa, Y; Kuga, T; Mohri, M; Shimokawa, H; Tagawa, T; Takeshita, A | 1 |
Cable, DG; Kullo, IJ; O'Brien, T; Pompili, VJ; Schaff, HV; Schwartz, RS | 1 |
John, S; Lackner, KJ; Langenfeld, MR; Schlaich, MP; Schmieder, RE; Schmitz, G | 1 |
Doi, H; Kawano, H; Kugiyama, K; Matsumura, T; Misumi, K; Motoyama, T; Nakagawa, O; Nakajima, K; Nakano, T; Ogawa, H; Soejima, H; Sugiyama, S; Yasue, H; Yoshimura, M | 1 |
Drexler, H; Hornig, B | 1 |
Nieminen, MS; Pajunen, P; Sinisalo, J; Vanhanen, H; Vapaatalo, H | 1 |
Crake, T; Davies, G; Katsimaglis, G; Stefanadis, C; Tentolouris, C; Tousoulis, D; Toutouzas, P | 1 |
Amoroso, G; Baglini, R; Limbruno, U; Mariani, M; Mariotti, R; Merelli, A; Paterni, G; Petronio, AS | 1 |
Arakawa, N; Hiramori, K; Nakamura, M; Yoshida, H | 1 |
Büttner, K; Drexler, H; Hornig, B; Landmesser, U; Merten, R; Spiekermann, S | 1 |
Adnot, S; Belhassen, L; Benacerraf, S; Carville, C; Dubois-Randé, JL; Sediame, S | 1 |
Gutterman, DD; Liu, Y; Loberiza, F; Miura, H; Terata, K | 1 |
Ahlersmann, D; Christoph, A; Drexler, H; Hornig, B; Kohler, C; Landmesser, U; Spiekermann, S; Tatge, H | 1 |
Chin-Dusting, JP; Dart, AM; Kingwell, BA; Shaw, JA | 1 |
Chan, N; Vallance, P | 1 |
Andrews, NP; Dakak, N; Husain, M; Quyyumi, AA | 1 |
Goto, M; Hiramatsu, O; Kajiya, F; Merkus, D; Nakamoto, H; Ogasawara, Y; Spaan, JA; Tachibana, H; Toyota, E; Vergroesen, I | 1 |
Biegelsen, ES; Duffy, SJ; Gokce, N; Holbrook, M; Keaney, JF; Russell, JD; Vita, JA | 1 |
2 review(s) available for omega-n-methylarginine and Coronary Disease
Article | Year |
---|---|
Endothelial dysfunction in human disease.
Topics: Acetylcholine; Ascorbic Acid; Cardiac Output, Low; Coronary Disease; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Humans; Hypercholesterolemia; Hyperemia; Lipoproteins, LDL; omega-N-Methylarginine; Radial Artery | 1999 |
Endothelial function and nitric oxide: clinical relevance.
Topics: Arginine; Cardiovascular Diseases; Coronary Disease; Endothelium, Vascular; Genetic Therapy; Humans; Nitric Oxide; omega-N-Methylarginine; Risk Factors; Sepsis; Vasoconstriction | 2001 |
6 trial(s) available for omega-n-methylarginine and Coronary Disease
Article | Year |
---|---|
Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease.
Topics: Acetylcholine; Adult; Age Factors; Brachial Artery; Coronary Disease; Enzyme Inhibitors; Forearm; Humans; Male; Nitroglycerin; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Vasodilation | 1996 |
Ursodeoxycholic acid and endothelial-dependent, nitric oxide-independent vasodilatation of forearm resistance arteries in patients with coronary heart disease.
Topics: Acetylcholine; Adult; Aged; Coronary Disease; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Forearm; Humans; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Ursodeoxycholic Acid; Vasodilation | 1999 |
Inhibition of nitric oxide synthesis in human epicardial coronary arteries and stenoses in relation to serum lipid level.
Topics: Adult; Angina Pectoris; Cholesterol; Coronary Angiography; Coronary Disease; Coronary Vessels; Enzyme Inhibitors; Exercise Test; Female; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Reference Values; Sensitivity and Specificity; Triglycerides; Vascular Patency; Vasoconstriction | 1999 |
Endothelium-dependent vasodilator response is augmented in peripheral resistance vessels of patients with vasospastic angina.
Topics: Acetylcholine; Adult; Aged; Blood Pressure; Coronary Disease; Coronary Vasospasm; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Forearm; Heart Rate; Humans; Male; Middle Aged; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Plethysmography; Regional Blood Flow; Vascular Resistance; Vasodilator Agents | 1999 |
Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ascorbic Acid; Biological Availability; Coronary Disease; Endothelium, Vascular; Enzyme Activation; Humans; Losartan; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxidative Stress; Radial Artery; Ramipril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Regional Blood Flow; Superoxide Dismutase; Time Factors; Vasodilation | 2001 |
Iron chelation improves endothelial function in patients with coronary artery disease.
Topics: Adult; Blood Flow Velocity; Coronary Disease; Deferoxamine; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Free Radical Scavengers; Humans; Infusions, Intra-Arterial; Iron; Iron Chelating Agents; Male; Methacholine Chloride; Middle Aged; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Plethysmography; Vasodilation; Vasomotor System | 2001 |
20 other study(ies) available for omega-n-methylarginine and Coronary Disease
Article | Year |
---|---|
Long-term treatment with eicosapentaenoic acid improves exercise-induced vasodilation in patients with coronary artery disease.
Topics: Acetylcholine; Aged; Blood Pressure; Coronary Disease; Drug Administration Schedule; Eicosapentaenoic Acid; Endothelium, Vascular; Enzyme Inhibitors; Exercise; Fatty Acids, Unsaturated; Forearm; Hand Strength; Heart Rate; Humans; Lipids; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Vasodilation; Vasodilator Agents | 2002 |
Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease.
Topics: Causality; Comorbidity; Coronary Disease; Endothelium, Vascular; Enzyme Inhibitors; Humans; Incidence; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Myocardial Ischemia; Nitric Oxide; omega-N-Methylarginine; Risk; Vasodilation | 2003 |
Exercise training enhances vasodilation responses to vascular endothelial growth factor in porcine coronary arterioles exposed to chronic coronary occlusion.
Topics: Animals; Arterioles; Chronic Disease; Collateral Circulation; Coronary Disease; Coronary Vessels; Culture Techniques; Enzyme Inhibitors; Female; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Physical Conditioning, Animal; Prostaglandins; Protein-Tyrosine Kinases; Swine; Vascular Endothelial Growth Factor A; Vasodilation; Vasodilator Agents | 2004 |
Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Coronary Disease; Enzyme Induction; Homocysteine; Imidazoles; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Myocardium; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Olmesartan Medoxomil; omega-N-Methylarginine; Oxidative Stress; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Superoxides; Tetrazoles; Thiazepines | 2004 |
Value of echocardiography for evaluation of the flow-dependent epicardial coronary vasodilation in vivo.
Topics: Animals; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Echocardiography; Enzyme Inhibitors; Female; Hyperemia; Male; Nitric Oxide Synthase; omega-N-Methylarginine; Regional Blood Flow; Vasodilation | 2005 |
Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries.
Topics: Administration, Topical; Animals; Arginine; Coronary Circulation; Coronary Disease; Dogs; Endothelium, Vascular; Enzyme Inhibitors; Hemodynamics; Injections, Intravenous; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Pericardium; Platelet Aggregation; Platelet Aggregation Inhibitors; Time Factors; Vasodilator Agents | 1996 |
Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans.
Topics: Acetylcholine; Adult; Aged; Cardiac Pacing, Artificial; Coronary Circulation; Coronary Disease; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Risk Factors; Tachycardia; Vasodilation; Vasomotor System | 1996 |
Basal and flow-mediated nitric oxide production by atheromatous coronary arteries.
Topics: Blood Flow Velocity; Cardiac Pacing, Artificial; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Disease; Enzyme Inhibitors; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Sodium Chloride; Ultrasonography, Doppler; Vasodilation | 1997 |
Inhibition of nitric oxide synthesis during the cold pressor test in patients with coronary artery disease.
Topics: Aged; Blood Pressure; Constriction, Pathologic; Coronary Angiography; Coronary Disease; Enzyme Inhibitors; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitric Oxide; Nitroglycerin; omega-N-Methylarginine; Vasoconstriction; Vasodilator Agents | 1997 |
Bradykinin-induced vasodilation of human coronary arteries in vivo: role of nitric oxide and angiotensin-converting enzyme.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Coronary Angiography; Coronary Disease; Coronary Vessels; Enalaprilat; Female; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Peptidyl-Dipeptidase A; Ultrasonography, Doppler; Ultrasonography, Interventional; Vasodilation | 1997 |
Expression and function of a recombinant endothelial nitric oxide synthase gene in porcine coronary arteries.
Topics: Adenoviridae; Analysis of Variance; Animals; Calcimycin; Coronary Disease; Coronary Vessels; Endothelium, Vascular; Gene Expression; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Immunohistochemistry; Ionophores; Nitric Oxide Synthase; Nitrites; omega-N-Methylarginine; Swine; Vasoconstriction | 1997 |
Does lipoprotein(a) impair endothelial function?
Topics: Acetylcholine; Adult; Arteriosclerosis; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Humans; Immunoelectrophoresis; Infusions, Intra-Arterial; Lipoprotein(a); Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Plethysmography; Regional Blood Flow; Regression Analysis; Risk Factors; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1998 |
Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries.
Topics: Acetylcholine; Adult; Aged; Coronary Angiography; Coronary Circulation; Coronary Disease; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Lipoproteins; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; omega-N-Methylarginine; Risk Factors | 1998 |
The impact of coronary artery disease on the coronary vasomotor response to nonionic contrast media.
Topics: Aged; Cardiovascular Agents; Contrast Media; Coronary Angiography; Coronary Circulation; Coronary Disease; Coronary Vessels; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Indomethacin; Male; Middle Aged; omega-N-Methylarginine; Oxygen; Time Factors; Triiodobenzoic Acids; Vasomotor System | 2000 |
Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; Coronary Disease; Coronary Vessels; Drug Combinations; Endothelium, Vascular; Enzyme Inhibitors; Extracellular Space; Humans; Hypercholesterolemia; Male; Middle Aged; omega-N-Methylarginine; Radial Artery; Reactive Oxygen Species; Superoxide Dismutase; Vasodilation | 2000 |
[Vasodilator effects of bradykinin on the resistive circulation of the forearm of coronary patients].
Topics: Acetylcholine; Adult; Aged; Aspirin; Bradykinin; Coronary Disease; Forearm; Humans; Infusions, Intra-Arterial; Male; Middle Aged; omega-N-Methylarginine; Platelet Aggregation Inhibitors; Reference Values; Regional Blood Flow; Vasodilation | 2000 |
Human coronary arteriolar dilation to adrenomedullin: role of nitric oxide and K(+) channels.
Topics: Adenine; Adrenomedullin; Aged; Arterioles; Calcitonin Gene-Related Peptide; Coronary Circulation; Coronary Disease; Coronary Vessels; Enzyme Inhibitors; Female; Heart Failure; Humans; Hypertension; In Vitro Techniques; Male; Microcirculation; Middle Aged; Miotics; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Peptide Fragments; Potassium Channels; Vasodilation; Vasodilator Agents | 2000 |
Diurnal variation in endothelium-dependent vasodilatation is not apparent in coronary artery disease.
Topics: Acetylcholine; Acute Disease; Analysis of Variance; Blood Glucose; Blood Pressure; Carrier Proteins; Cholesterol; Circadian Rhythm; Coronary Disease; Cyclic AMP Receptor Protein; Endothelium, Vascular; Forearm; Heart Rate; Hemodynamics; Humans; Hydrocortisone; Interleukin-6; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Plethysmography; Triglycerides; Vasodilation | 2001 |
Platelet inhibitory effect of nitric oxide in the human coronary circulation: impact of endothelial dysfunction.
Topics: Acetylcholine; Adult; Aged; Coronary Circulation; Coronary Disease; Coronary Thrombosis; Cyclic GMP; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Platelet Activation | 2001 |
Stenosis differentially affects subendocardial and subepicardial arterioles in vivo.
Topics: Animals; Arterioles; Blood Pressure; Coronary Circulation; Coronary Disease; Dogs; Endocardium; Heart; Heart Rate; Hemodynamics; Homeostasis; Microscopy, Video; omega-N-Methylarginine; Pacemaker, Artificial; Pericardium; Reference Values; Vascular Resistance | 2001 |